Real-time enrollment status for this eosinophilic esophagitis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 2:25 PM UTC
| NCT Number | NCT06596252 |
| Recruiting Status | Recruiting |
| Condition | Eosinophilic Esophagitis |
| Phase | PHASE3 |
| Target Enrollment | 308 participants |
| Active Locations | 26 sites in the US |
| Sponsor | Dr. Falk Pharma GmbH |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT06596252 is currently recruiting participants. This phase3 study for eosinophilic esophagitis is actively seeking new participants at 26 locations across the United States. The study is sponsored by Dr. Falk Pharma GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06596252 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06596252 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.